PLA2R1 and prostate cancer: We attempted to exclude methodology-associated errors (genotypic artefacts or cross contaminations) that might be involved as potential confounding factors in diversification of PLA2R1 expression in the analysed prostate cancer cell lines by short tandem repeat analysis.